Sarmal, Inc. logo

Sarmal, Inc.

A genomics company developing next generation innovations in sequencing and advanced target sequence detection

5 employees · est. 2019 · Istanbul

VS
TwinStrand Biosciences logo

TwinStrand Biosciences

Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinStrand Duplex Sequencing

24 employees · est. 2015

TwinStrand Biosciences is the older company (2019 vs 2015); TwinStrand Biosciences is the larger of the two.

Side-by-Side Comparison

Sarmal, Inc. TwinStrand Biosciences
Founded
2019 2015 older
Headquarters
Istanbul Not tracked yet
Employees
5 24 larger
Industry
Digital Health, Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $83.50M
Funding Rounds
Not tracked yet 5
Services
Development of next-generation innovations in sequencing and advanced target sequence detection Not tracked yet
Target Customers
Research institutions, biotechnology companies, healthcare organizations Not tracked yet
Taxonomy
Genomics, DNA Sequencing, Target Sequence Detection, Sequencing Technology, Nucleic Acid-based Diagnostics, Portable Diagnostic Platform, Field Deployable Technology, Single Molecule Sequencing, Next Generation Sequencing, Advanced Sequencing Technology, Diagnostic Devices, Error Rate Reduction, Population Screening, Cost-effective Genomics Genomic Sequencing, Duplex Sequencing, Ultra-rare Variant Detection, Precision Genomics, NGS Technology, Cancer Detection, Genetic Toxicology, Public Health, Pharmaceutical Research, Molecular Diagnostics, Genetic Health, Forensic Science, Mutation Detection, Bioinformatics
Website
sarmal.com twinstrandbio.com
Sarmal, Inc. logo

About Sarmal, Inc.

Sarmal, Inc. is a genomics company focused on developing next generation innovations in sequencing and advanced target sequence detection. The company's FLASH Sequencing technology, a single molecule DNA sequencing approach, is a game changer in the genomics field, enabling whole genome sequencing a...

TwinStrand Biosciences logo

About TwinStrand Biosciences

TwinStrand Biosciences is a biotechnology and healthcare startup founded in 2015. The company's groundbreaking Duplex Sequencing patent estate underpins the capacity to accurately identify ultra-low frequency genomic variants, unnoticeable by traditional NGS methods. The patented technology not only...

We will tell you when either one moves

BounceWatch watches Sarmal, Inc. and TwinStrand Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Sarmal, Inc. and TwinStrand Biosciences — by email.

Frequently Asked Questions

Sarmal, Inc. — A genomics company developing next generation innovations in sequencing and advanced target sequence detection. TwinStrand Biosciences — Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinStrand Duplex Sequencing . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Sarmal, Inc. has raised undisclosed funding while TwinStrand Biosciences has raised $83.50M.
Sarmal, Inc. and TwinStrand Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Sarmal, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Sarmal, Inc. on 25 Mar 2025, and TwinStrand Biosciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy